HongZhangMD

Breast Cancer, Head & Neck, Urologic Cancer

Chief of Highland Radiation Oncology, Professor, University of Rochester School of Medicine & Dentistry

Dr. Zhang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Hong Zhang is a radiation oncologist in Rochester, NY and is affiliated with multiple hospitals in the area, including Highland Hospital and Strong Memorial Hospital of the University of Rochester. She received her medical degree from Yale University School of Medicine and has been in practice 18 years. She also speaks multiple languages, including Chinese (Mandarin). She specializes in prostate cancer, brachytherapy, and head & neck cancer.

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

PubMed

Stroke death in patients receiving radiation for head and neck cancer in the modern era.
Sara J Hardy, Sanjukta Bandyopadhyay, Hongmei Yang, Annalynn Williams, Abdi Gudina
Frontiers in Oncology. 2023-01-01
8 citations
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer.
Sarah L Kerns, Ashley Amidon Morlang, Sharon M Lee, Derick R Peterson, Brian Marples
Radiotherapy and Oncology. 2022-03-01
Increased risk of high-grade prostate cancer among testicular cancer survivors.
Hong Zhang, Hongmei Yang, Sanjukta Bandyopadhyay, Michael T Milano, Chunkit Fung
Plos One. 2022-01-01

Journal Articles

Impact of radiotherapy on laryngeal cancer survival: a population-based study of 13,808 US patients.
Zhang H1, Travis LB, Chen R, Hyrien O, Milano MT, Newlands SD, Chen Y., Cancer. 2012 Mar 1;118(5):1276-87.